• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型吡咯烷衍生物作为基质金属蛋白酶抑制剂的设计、合成及初步评价

Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.

作者信息

Cheng Xian-Chao, Wang Qiang, Fang Hao, Tang Wei, Xu Wen-Fang

机构信息

Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, No. 44 Wenhuaxi Road, Jinan 250012, China.

出版信息

Eur J Med Chem. 2008 Oct;43(10):2130-9. doi: 10.1016/j.ejmech.2007.12.020. Epub 2007 Dec 31.

DOI:10.1016/j.ejmech.2007.12.020
PMID:18362041
Abstract

A series of novel pyrrolidine derivatives were designed, synthesized and assayed for their inhibitory activities on matrix metalloproteinase 2 (MMP-2) and aminopeptidase N (AP-N). The results showed that these pyrrolidine derivatives exhibited highly selective inhibition against MMP-2 as compared with AP-N. The hydroxamates 8a-c were equally or more potent MMP-2 inhibitors than the positive control LY52. The binding mode of the most potent compound 8a with MMP-2 was proposed. Structure-activity relationships were also briefly discussed.

摘要

设计、合成了一系列新型吡咯烷衍生物,并测定了它们对基质金属蛋白酶2(MMP-2)和氨肽酶N(AP-N)的抑制活性。结果表明,与AP-N相比,这些吡咯烷衍生物对MMP-2表现出高度选择性抑制。异羟肟酸酯8a-c作为MMP-2抑制剂的活性与阳性对照LY52相当或更强。提出了最有效的化合物8a与MMP-2的结合模式。还简要讨论了构效关系。

相似文献

1
Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.新型吡咯烷衍生物作为基质金属蛋白酶抑制剂的设计、合成及初步评价
Eur J Med Chem. 2008 Oct;43(10):2130-9. doi: 10.1016/j.ejmech.2007.12.020. Epub 2007 Dec 31.
2
Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.新型磺酰基吡咯烷衍生物作为基质金属蛋白酶抑制剂的设计、合成与评价
Bioorg Med Chem. 2008 May 15;16(10):5398-404. doi: 10.1016/j.bmc.2008.04.027. Epub 2008 Apr 15.
3
Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.新型磺酰基吡咯烷衍生物作为基质金属蛋白酶抑制剂的合成
Bioorg Med Chem. 2008 Sep 1;16(17):7932-8. doi: 10.1016/j.bmc.2008.07.073. Epub 2008 Jul 30.
4
Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.新型3-没食子酰氨基-N'-取代-2,6-哌啶二酮-N-乙酰胺肽模拟物作为金属蛋白酶抑制剂
Bioorg Med Chem Lett. 2007 May 15;17(10):2935-8. doi: 10.1016/j.bmcl.2006.12.095. Epub 2007 Jan 5.
5
[Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].基于酶结构的新型基质金属蛋白酶抑制剂的设计、合成与活性评价
Yao Xue Xue Bao. 2007 Dec;42(12):1271-81.
6
Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.具有 l-精氨酸骨架的双肽或三肽类似物的设计、合成及作为氨基肽酶 N/CD13 抑制剂的初步活性测定。
Bioorg Med Chem. 2010 Jan 15;18(2):887-95. doi: 10.1016/j.bmc.2009.11.036. Epub 2009 Nov 22.
7
Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.新型赖氨酸衍生物作为氨基肽酶N/CD13抑制剂的设计、合成及定量构效关系研究
Bioorg Med Chem. 2008 May 15;16(10):5473-81. doi: 10.1016/j.bmc.2008.04.012. Epub 2008 Apr 11.
8
Design and synthesis of novel metalloproteinase inhibitors.新型金属蛋白酶抑制剂的设计与合成。
Bioorg Med Chem. 2006 Aug 1;14(15):5402-22. doi: 10.1016/j.bmc.2006.03.032. Epub 2006 Apr 18.
9
Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).新型基于喹喔啉酮骨架的基质金属蛋白酶抑制剂(第一部分)。
Bioorg Med Chem. 2010 Feb 15;18(4):1516-25. doi: 10.1016/j.bmc.2010.01.008. Epub 2010 Jan 11.
10
Design and synthesis of an orally active matrix metalloproteinase inhibitor.一种口服活性基质金属蛋白酶抑制剂的设计与合成。
Bioorg Med Chem. 2006 Sep 15;14(18):6383-403. doi: 10.1016/j.bmc.2006.05.040. Epub 2006 Jun 9.

引用本文的文献

1
Unveiling the research directions for pyrrolidine-based small molecules as versatile antidiabetic and anticancer agents.揭示基于吡咯烷的小分子作为多功能抗糖尿病和抗癌药物的研究方向。
Future Med Chem. 2025 May;17(9):1039-1053. doi: 10.1080/17568919.2025.2501923. Epub 2025 May 12.
2
Harnessing the metastatic potential of human osteosarcoma cells by natural coumarin galbanic acid.利用天然香豆素没药酸激发人骨肉瘤细胞的转移潜能。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 7. doi: 10.1007/s00210-025-04128-5.
3
Progress in the Stereoselective Synthesis Methods of Pyrrolidine-Containing Drugs and Their Precursors.
含吡咯烷类药物及其前体的立体选择性合成方法的研究进展。
Int J Mol Sci. 2024 Oct 17;25(20):11158. doi: 10.3390/ijms252011158.
4
Molecular Docking Compounds of Cinnamaldehyde Derivatives as Anticancer Agents.肉桂醛衍生物的分子对接化合物作为抗癌剂。
Asian Pac J Cancer Prev. 2021 Aug 1;22(8):2409-2419. doi: 10.31557/APJCP.2021.22.8.2409.
5
Molecular docking and inhibition of matrix metalloproteinase-2 by novel difluorinatedbenzylidene curcumin analog.新型二氟苯乙烯基姜黄素类似物对基质金属蛋白酶-2 的分子对接和抑制作用。
Am J Transl Res. 2015 Feb 15;7(2):298-308. eCollection 2015.
6
Exploration of structural and physicochemical requirements and search of virtual hits for aminopeptidase N inhibitors.探索氨基肽酶 N 抑制剂的结构和物理化学要求及虚拟筛选。
Mol Divers. 2013 Feb;17(1):123-37. doi: 10.1007/s11030-013-9422-5. Epub 2013 Jan 23.